Process View
A cell cycle checkpoint that detects and negatively regulates progression from G1 to S phase in the cell cycle in response to DNA damage.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "g1 dna damage checkpoint"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| TP53 | tumor protein p53 | 1.000 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.995 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.983 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.974 | Human | |
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.903 | Human | |
| CASP2 | caspase 2, apoptosis-related cysteine peptidase | 0.815 | ||
| PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.711 | ||
| RB1 | retinoblastoma 1 | 0.670 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.606 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.518 | ||
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.470 | ||
| CCND3 | cyclin D3 | 0.367 | Human | |
| APAF1 | apoptotic peptidase activating factor 1 | 0.337 | ||
| PAX3 | paired box 3 | 0.332 | ||
| LRDD | leucine-rich repeats and death domain containing | 0.228 | ||
| IER3 | immediate early response 3 | 0.223 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.209 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.203 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.189 | ||
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.185 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.171 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.146 | ||
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.141 | Human | |
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.138 | Human | |
| CDK2 | cyclin-dependent kinase 2 | 0.134 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.126 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.123 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.121 | Human | |
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.110 | ||
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.101 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.101 | Human | |
| UBE2B | ubiquitin-conjugating enzyme E2B (RAD6 homolog) | 0.087 | Yeast | |
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.087 | ||
| GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | 0.076 | ||
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.073 | ||
| STRN3 | striatin, calmodulin binding protein 3 | 0.071 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.067 | ||
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.063 | Human | |
| FADD | Fas (TNFRSF6)-associated via death domain | 0.058 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.058 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.055 | ||
| SKP1 | S-phase kinase-associated protein 1 | 0.054 | ||
| RPA1 | replication protein A1, 70kDa | 0.054 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.053 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.052 | ||
| CCND1 | cyclin D1 | 0.051 | ||
| UBR3 | ubiquitin protein ligase E3 component n-recognin 3 (putative) | 0.050 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.044 | Human | |
| UBE2D2 | ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast) | 0.044 | ||
| KRT5 | keratin 5 | 0.043 | ||
| SMAD7 | SMAD family member 7 | 0.040 | ||
| RBL1 | retinoblastoma-like 1 (p107) | 0.036 | ||
| DAXX | death-domain associated protein | 0.033 | ||
| WWOX | WW domain containing oxidoreductase | 0.033 | ||
| RNF20 | ring finger protein 20 | 0.031 | ||
| MKRN1 | makorin ring finger protein 1 | 0.030 | ||
| MED1 | mediator complex subunit 1 | 0.030 | ||
| BRCA1 | breast cancer 1, early onset | 0.029 | ||
| BIRC2 | baculoviral IAP repeat containing 2 | 0.029 | ||
| PPP2R5D | protein phosphatase 2, regulatory subunit B', delta | 0.029 | Human | |
| PPM1D | protein phosphatase, Mg2+/Mn2+ dependent, 1D | 0.028 | ||
| CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.027 | ||
| CCNE1 | cyclin E1 | 0.027 | ||
| UBE2D1 | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 0.026 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.026 | ||
| NOTCH1 | notch 1 | 0.026 | ||
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.025 | ||
| RAD18 | RAD18 homolog (S. cerevisiae) | 0.025 | ||
| CCND2 | cyclin D2 | 0.024 | Human | |
| SATB2 | SATB homeobox 2 | 0.024 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.023 | Human | |
| RYBP | RING1 and YY1 binding protein | 0.022 | ||
| MARCKSL1 | MARCKS-like 1 | 0.022 | ||
| MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.021 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.020 | ||
| UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.020 | ||
| SALL2 | sal-like 2 (Drosophila) | 0.019 | ||
| CSNK1A1 | casein kinase 1, alpha 1 | 0.019 | ||
| FOXD3 | forkhead box D3 | 0.018 | ||
| PPFIA1 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | 0.018 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.018 | ||
| CCNA1 | cyclin A1 | 0.018 | ||
| UBE2D3 | ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) | 0.018 | ||
| GORAB | golgin, RAB6-interacting | 0.018 | ||
| OTUB1 | OTU domain, ubiquitin aldehyde binding 1 | 0.017 | ||
| YAP1 | Yes-associated protein 1 | 0.017 | ||
| RPA2 | replication protein A2, 32kDa | 0.017 | ||
| PCGF2 | polycomb group ring finger 2 | 0.016 | ||
| TERT | telomerase reverse transcriptase | 0.016 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.016 | ||
| RBL2 | retinoblastoma-like 2 (p130) | 0.015 | ||
| EP300 | E1A binding protein p300 | 0.015 | ||
| PPME1 | protein phosphatase methylesterase 1 | 0.015 | ||
| BTRC | beta-transducin repeat containing | 0.014 | ||
| DZIP1 | DAZ interacting protein 1 | 0.014 | ||
| CUX1 | cut-like homeobox 1 | 0.013 | ||
| ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.013 | ||
| SIAH1 | seven in absentia homolog 1 (Drosophila) | 0.013 | ||
| CASP8AP2 | caspase 8 associated protein 2 | 0.013 | ||
| NBN | nibrin | 0.013 | ||
| RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.013 | ||
| YY1 | YY1 transcription factor | 0.013 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.012 | ||
| RAD51 | RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) | 0.012 | ||
| CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | 0.012 | ||
| RIOK3 | RIO kinase 3 (yeast) | 0.012 | ||
| POLH | polymerase (DNA directed), eta | 0.011 | ||
| USP2 | ubiquitin specific peptidase 2 | 0.011 | ||
| MDFI | MyoD family inhibitor | 0.011 | ||
| RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 | 0.011 | ||
| S100A2 | S100 calcium binding protein A2 | 0.011 | ||
| KRT6C | keratin 6C | 0.011 | ||
| IFI16 | interferon, gamma-inducible protein 16 | 0.011 | ||
| RRM2B | ribonucleotide reductase M2 B (TP53 inducible) | 0.011 | ||
| S1PR5 | sphingosine-1-phosphate receptor 5 | 0.011 | ||
| PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha | 0.010 | ||
| SMC1A | structural maintenance of chromosomes 1A | 0.010 | ||
| UNG | uracil-DNA glycosylase | 0.010 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.010 |